The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients.
Osnat ElyashivNatalie AleohinZohar MigdanSophia LeytesOfri PeledOri TalTally LevyPublished in: Cancers (2024)
Platinum resistance is an important prognostic factor in women with EOC. Patients with SPR acquire the same poor treatment outcome as with PPR. There is a great need for future research efforts to discover novel strategies and biological treatments to reverse resistance and improve survival.